Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population

被引:23
作者
Ekstein, J
Rubin, BY
Anderson, SL
Weinstein, DA
Bach, G
Abeliovich, D
Webb, M
Risch, N
机构
[1] Dor Yeshorim, Committee Prevent Jewish Genet Dis, Brooklyn, NY 11211 USA
[2] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA
[3] Childrens Hosp, Div Endocrinol, Dept Med, Boston, MA USA
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel
[6] Tepnel Diagnost Ltd, Abingdon, Oxon, England
[7] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA
[8] Kaiser Permanente, Div Res, Oakland, CA USA
关键词
glycogen storage disease type Ia; Ashkenazi Jews; glucose-6-phosphatase;
D O I
10.1002/ajmg.a.30232
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Glycogen storage disease type la (GSDIa) is a severe autosomal recessive disorder caused by deficiency of the enzyme D-glucose-6-phosphatase (G6Pase). While numerous mutations have been found in cosmopolitan European populations, Ashkenazi Jewish (AJ) patients appear to primarily carry the R83C mutation, but possibly also the Q347X mutation found generally in Caucasians. To determine the frequency for both these mutations in the AJ population, we tested 20,719 AJ subjects for the R83C mutation and 4,290 subjects for the Q347X mutation. We also evaluated the mutation status of 30 AJ GSDIa affected subjects. From the carrier screening, we found 290 subjects with R83C, for a carrier frequency for this mutation of 1.4%. This carrier frequency translates into a predicted disease prevalence of 1 in 20,000, five times higher than for the general Caucasian population, confirming a founder effect and elevated frequency of GSDIa in the AJ population. We observed no carriers of the Q347X mutation. Among the 30 GSDIa affected AJ subjects, all were homozygous for R83C. These results indicate that R83C is the only prevalent mutation for GSDIa in the Ashkenazi population. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:162 / 164
页数:3
相关论文
共 14 条
[1]  
Abeliovich D, 1996, EUR J HUM GENET, V4, P338
[2]  
Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO
[3]  
2-0
[4]   SCREENING FOR CARRIERS OF TAY-SACHS-DISEASE IN THE ULTRAORTHODOX ASHKENAZI JEWISH-COMMUNITY IN ISRAEL [J].
BROIDE, E ;
ZEIGLER, M ;
ECKSTEIN, J ;
BACH, G .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 47 (02) :213-215
[5]  
LEI KJ, 1995, AM J HUM GENET, V57, P766
[6]   MUTATIONS IN THE GLUCOSE-6-PHOSPHATASE GENE THAT CAUSE GLYCOGEN-STORAGE-DISEASE TYPE-1A [J].
LEI, KJ ;
SHELLY, LL ;
PAN, CJ ;
SIDBURY, JB ;
CHOU, JY .
SCIENCE, 1993, 262 (5133) :580-583
[7]   ANALYSIS OF ANY POINT MUTATION IN DNA - THE AMPLIFICATION REFRACTORY MUTATION SYSTEM (ARMS) [J].
NEWTON, CR ;
GRAHAM, A ;
HEPTINSTALL, LE ;
POWELL, SJ ;
SUMMERS, C ;
KALSHEKER, N ;
SMITH, JC ;
MARKHAM, AF .
NUCLEIC ACIDS RESEARCH, 1989, 17 (07) :2503-2516
[8]  
Parvari R, 1997, AM J MED GENET, V72, P286, DOI 10.1002/(SICI)1096-8628(19971031)72:3<286::AID-AJMG6>3.0.CO
[9]  
2-P
[10]  
Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI [10.1007/BF02679990, 10.1007/s00431-002-0999-4]